Literature DB >> 15978742

IMRT for adjuvant radiation in gastric cancer: a preferred plan?

Jolie Ringash1, Greg Perkins, James Brierley, Gina Lockwood, Mohammad Islam, Pamela Catton, Bernard Cummings, John Kim, Rebecca Wong, Laura Dawson.   

Abstract

PURPOSE: To assess the potential advantage of intensity-modulated radiotherapy (IMRT) over conformal planning for postoperative adjuvant radiotherapy in patients with gastric carcinoma. METHODS AND MATERIALS: Twenty patients who had undergone treatment planning with conformal beam arrangements for 4500 cGy adjuvant radiotherapy between 2000 and 2001 underwent repeat planning using IMRT techniques. Conformal five-field plans were compared with seven- to nine-field coplanar sliding-window IMRT plans. For each patient, the cumulative dose-volume histograms and organ-dose summaries (without distributions or digitally reconstructed radiographs) were provided to two independent, "blinded" GI radiation oncologists. The oncologists indicated which plan provided better planning target volume coverage and critical organ sparing, any safety concerns with either plan, and which plan they would choose to treat the patient.
RESULTS: In 18 (90%) of 20 cases, both oncologists chose the same plan. Cases with disagreement were given to a third "blinded" reviewer. A "preferred plan" could be determined in 19 (95%) of 20 cases. IMRT was preferred in 17 (89%) of 19 cases. In 4 (20%) of 20 IMRT plans at least one radiation oncologist had safety concerns because of the spinal cord dose (3 cases) or small bowel dose (2 cases). Of 42 ratings, IMRT was thought to provide better planning target volume coverage in 36 (86%) and better sparing of the spinal cord in 31 (74%) of 42, kidneys in 29 (69%), liver in 30 (71%), and heart in 29 (69%) of 42 ratings. The median underdose volume (1.7 vs. 4.1 cm3), maximal dose to the spinal cord (36.85 vs. 45.65 Gy), and dose to 50% of the liver (17.29 vs. 27.97), heart (12.89 vs. 15.50 Gy), and left kidney (15.50 vs. 16.06 Gy) were lower with IMRT than with the conformal plans.
CONCLUSION: Compared with the conformal plans, oncologists frequently preferred IMRT plans when using dose-volume histogram data. The advantages of IMRT plans include both improved planning target volume coverage and improved sparing of critical organs. We are currently studying organ motion in the upper abdomen as a prerequisite to using IMRT for actual patient treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15978742     DOI: 10.1016/j.ijrobp.2005.03.013

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer.

Authors:  Cem Onal; Mustafa Cengiz; Ozan C Guler; Yemliha Dolek; Serdar Ozkok
Journal:  Br J Radiol       Date:  2017-03-24       Impact factor: 3.039

2.  Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma.

Authors:  Yeona Cho; Tae Hyung Kim; Jinsil Seong
Journal:  Strahlenther Onkol       Date:  2017-04-19       Impact factor: 3.621

Review 3.  Chemoradiation for gastric cancer: controversies, updates and novel techniques.

Authors:  M Fan; W Hu; Z Zhang
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

4.  Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT.

Authors:  Kk Murthy; Ka Shukeili; Ss Kumar; Ca Davis; Rr Chandran; S Namrata
Journal:  Biomed Imaging Interv J       Date:  2010-07-01

5.  Can we obtain planning goals for conformal techniques in neoadjuvant and adjuvant radiochemotherapy for gastric cancer patients?

Authors:  Wojciech Leszczyński; Paweł Polanowski; Paulina Leszczyńska; Leszek Hawrylewicz; Iwona Brąclik; Rafał Kawczyński; Jerzy Wydmański
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-08

Review 6.  Current adjuvant treatment modalities for gastric cancer: From history to the future.

Authors:  Leyla Kilic; Cetin Ordu; Ibrahim Yildiz; Fatma Sen; Serkan Keskin; Rumeysa Ciftci; Kezban Nur Pilanci
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

7.  Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.

Authors:  Xin Wang; Jing Jin; Ye-Xiong Li; Hua Ren; Hui Fang; Shu-Lian Wang; Yue-Ping Liu; Wei-Hu Wang; Zi-Hao Yu; Yong-Wen Song; Xin-Fan Liu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

8.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

Review 9.  Intensity-modulated radiation therapy for gastrointestinal tumors.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

10.  Usefulness of chemoradiotherapy for inoperable gastric cancer.

Authors:  T Taki; Y Hoya; A Watanabe; T Nakayoshi; T Okamoto; H Sekine; N Mitsumori; K Yanaga
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.